Literature DB >> 22825041

Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.

Babak Shafiei1, Samaneh Hoseinzadeh, Fereidoun Fotouhi, Hadi Malek, Fereidoun Azizi, Adel Jahed, Farzad Hadaegh, Mohammadtaghi Salehian, Hossein Parsa, Hamid Javadi, Majid Assadi.   

Abstract

BACKGROUND: Investigations using a hybrid single photon emission computed tomography/computed tomography (SPECT-CT) scanning technique have been carried out in limited studies and have shown mixed results. However, the assessment of this technique for the detection of parathyroid adenoma in patients with a nodular goiter was performed in only one study with a small sample size. The aim of this prospective study was to assess the role of 99mTc-sestamibi parathyroid SPECT-CT scans for localization of parathyroid adenomas with a concomitant nodular goiter using 99mTc-methoxyisobutyl isonitrile (MIBI) scintigraphy and to compare it with SPECT and planar imaging.
METHODS: This study was conducted on 48 patients with primary hyperparathyroidism and nodular goiter, who were candidates for parathyroid surgery and had been referred for parathyroid scintigraphy. The patients underwent an early set of planar 99mTc-MIBI scanning procedures first, followed by SPECT and CT scannings, and finally a delayed set of planar 99mTc-MIBI scannings. Sensitivity, specificity, negative and positive predictive values, and accuracy were determined on a per-parathyroid-gland basis for each scanning method, as defined by histology and follow-up.
RESULTS: The surgery was successful in 48 out of 50 patients with primary hyperparathyroidism concomitant with thyroid nodularity, and data were completed for 80 sites in 48 patients. The accuracy of SPECT-CT in correctly identifying a parathyroid adenoma was 85.00, versus 75.00% for SPECT (P=0.01, significant). The sensitivity and specificity for SPECT-CT were 77.55 and 96.77%, respectively, versus 67.34 and 87.09%, respectively, for SPECT (P=0.12 and 0.12, not significant). There were nine sites that showed better localization on SPECT-CT scans relative to SPECT images, of which five sites were located in the ectopic regions.
CONCLUSION: The results of our study indicate that SPECT-CT is more accurate than sestamibi planar imaging and SPECT for the preoperative identification of parathyroid lesions in patients with primary hyperparathyroidism concomitant with thyroid nodularity. Also, we would recommend the use of SPECT-CT for a workup of all patients with ectopic glands who are scheduled for minimally invasive parathyroid surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825041     DOI: 10.1097/MNM.0b013e32835710b6

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  12 in total

Review 1.  SPECT/CT and tumour imaging.

Authors:  Gad Abikhzer; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-29       Impact factor: 9.236

2.  Preoperative ¹¹C-methionine PET/CT enables focused parathyroidectomy in MIBI-SPECT negative parathyroid adenoma.

Authors:  Christina Lenschow; Peter Gassmann; Christian Wenning; Norbert Senninger; Mario Colombo-Benkmann
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

3.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

4.  Clinical Utility of Tc-99m MIBI SPECT/CT for Preoperative Localization of Parathyroid Lesions.

Authors:  Zeynep Gozde Ozkan; Seher Nilgun Unal; Serkan Kuyumcu; Yasemin Sanli; Mehmet Fatih Gecer; Beyza Ozcinar; Yasemin Senyurek Giles; Yesim Erbil
Journal:  Indian J Surg       Date:  2016-05-04       Impact factor: 0.656

5.  Usefulness of SPECT/CT in Parathyroid Lesion Detection in Patients with Thyroid Parenchymal 99mTc-Sestamibi Retention.

Authors:  Sang Hyun Hwang; Yumie Rhee; Mijin Yun; Jung Hyun Yoon; Jeong Won Lee; Arthur Cho
Journal:  Nucl Med Mol Imaging       Date:  2016-07-28

6.  Deep learning-based detection of parathyroid adenoma by 99mTc-MIBI scintigraphy in patients with primary hyperparathyroidism.

Authors:  Atsushi Yoshida; Daiju Ueda; Shigeaki Higashiyama; Yutaka Katayama; Toshimasa Matsumoto; Takashi Yamanaga; Yukio Miki; Joji Kawabe
Journal:  Ann Nucl Med       Date:  2022-02-18       Impact factor: 2.258

7.  The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism.

Authors:  Mechteld C de Jong; K Jamal; S Morley; T Beale; T Chung; S Jawad; S Hurel; H Simpson; U Srirangalingam; S E Baldeweg; V Rozalén García; S Otero; M Shawky; T E Abdel-Aziz; T R Kurzawinski
Journal:  Hormones (Athens)       Date:  2020-05-13       Impact factor: 2.885

8.  SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism.

Authors:  Yoshio Monzen; Akihisa Tamura; Hajime Okazaki; Taichi Kurose; Masayuki Kobayashi; Masatsugu Kuraoka
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

9.  Incremental role of 18F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism.

Authors:  Abhishek Behera; Nishikant Avinash Damle
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

Review 10.  Comparative Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism; Systematic Review and Meta- Analysis

Authors:  Reza Nafisi Moghadam; Amir Pasha Amlelshahbaz; Nasim Namiranian; Mohammad Sobhan-Ardekani; Mahmood Emami-Meybodi; Ali Dehghan; Masoud Rahmanian; Seid Kazem Razavi-Ratki
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.